July 19, 2007 – AtCor Medical Holdings Ltd., the developer and marketer of the SphygmoCor system, which noninvasively measures central blood pressures, announced that it has signed an $1.8 million deal with three leading international pharmaceutical companies to supply SphygmoCor systems and clinical trial support services for new and ongoing drug trials in Europe and the United States.
As noninvasive central blood pressure assessment reveals important drug effects that cannot be detected by traditional cuff blood pressure measurements, the market for noninvasive central blood pressure monitoring has become increasingly important among the pharmaceutical, clinical and research communities.
For more information: www.atcormedical.com